Studies Support Use of Daily Antibiotic to Prevent STDs in High-Risk Groups

• Ernie Mundell HealthDay Reporter
• July 19, 2024
• Full Page

It's long been known that popping the antibiotic doxycycline within 72 hours of a risky sexual encounter can greatly reduce a person's risk for a sexually transmitted infection (STI).

In fact, the U.S. Centers for Dis...

CDC Supports Use of Antibiotic as 'Morning After Pill' to Stop STDs

• Robin Foster HealthDay Reporter
• June 5, 2024
• Full Page

In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of some sexually transmitted diseases (STDs).

The latest recommendations only apply to gay and bisexual ...

Cases of Drug-Resistant Gonorrhea Have Tripled in China, Posing a Global Threat

• Ernie Mundell HealthDay Reporter
• March 28, 2024
• Full Page

A strain of highly antibiotic-resistant gonorrhea first emerged in China in 2016, and cases of this tough-to-treat infection have tripled there in just five years, Chinese researchers rep...

Antibiotic After Sex Slashed STD Rates in Study

• Robin Foster HealthDay Reporter
• March 5, 2024
• Full Page

Just one dose of the antibiotic doxycycline taken after sex halved the number of chlamydia and syphilis cases in San Francisco, promising new research shows.

In the study, gay and bisexual men and transgender women who had a history of sexually transmitted infections or ...

Taking Antibiotic After Sex Could Slash Your Risk for an STI. Here's What to Know

• Ernie Mundell HealthDay Reporter
• November 18, 2023
• Full Page

Data showing that the antibiotic doxycycline might prevent a sexually transmitted infection (STI) if taken soon after sex made headlines earlier this year.

As surging numbers of cases of syphilis and gonorrhea affect m...

FDA Approves First At-Home Test for Chlamydia, Gonorrhea

• Dennis Thompson HealthDay Reporter
• November 16, 2023
• Full Page

The first home test for chlamydia and gonorrhea will soon hit the market, following its approval Wednesday by the U.S. Food and Drug Administration.

People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen in the comfort of their home ...

New Antibiotic Tackles Drug-Resistant Gonorrhea in Trial

• Cara Murez HealthDay Reporter
• November 3, 2023
• Full Page

The first new antibiotic for gonorrhea -- the second most common sexually transmitted disease -- has shown promise in a clinical trial.

That news should come as a relief to public health experts, because gonorrhea has become resistant to all but one of the existing antib...

STDs Continue to Climb in the U.S.

• Cara Murez HealthDay Reporter
• April 11, 2023
• Full Page

Sexually transmitted infections (STIs) are surging in the United States, with notable increases seen in case counts of syphilis, gonorrhea and chlamydia.

Overall, STIs grew by 7% in 2021, reaching 2.5 million cases, according to the